- Home
- LIQT vs SER Comparison
LIQT vs SER Comparison
Compare LIQT & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LIQT | SER |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | Denmark | United States |
| Employees | N/A | 13 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 19.4M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | LIQT | SER |
|---|---|---|
| Price | $1.89 | $1.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $4.30 | ★ $15.00 |
| AVG Volume (30 Days) | 13.0K | ★ 71.8K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $42.12 | N/A |
| Revenue Next Year | $63.48 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.22 | $1.22 |
| 52 Week High | $3.35 | $7.92 |
Technical Indicators
Market Signals| Indicator | LIQT | SER |
|---|---|---|
| Relative Strength Index (RSI) | 39.05 | 57.54 |
| Support Level | $1.78 | $1.76 |
| Resistance Level | $2.06 | $2.30 |
| Average True Range (ATR) | 0.20 | 0.18 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 6.48 | 92.59 |
Price Performance
Historical ComparisonAbout LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is renowned in three business areas: ceramic membranes and membrane incorporated liquid filtration systems, ceramic diesel particulate filters (DPFs) to control soot exhaust particles and black carbon emission from diesel engines, and plastic components for usage across various industries. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, Hybrid Technology Membranes and others. The Company operates through three reportable segments: Systems and Aftermarket, Filters and Membranes, and Components.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.